Reversing increased neuronal nitric oxide synthase in Alzheimer’s disease prevents aberrant glutamatergic calcium responses
Rachelle Balez(Illawarra Health and Medical Research Institute), Lezanne Ooi(University of Wollongong), Greg T. Sutherland(Griffith University), Kuldip Sidhu(New South Wales Department of Health), Kerstin Lenk(Tampere University), Simon Maksour(University of Wollongong), Claire H. Stevens(University of Wollongong)
Cited by 0
Related Papers
TRPV3 is a temperature-sensitive vanilloid receptor-like protein
|Nature|2002|851
Chromatin crosstalk in development and disease: lessons from REST
|Nature Reviews Genetics|2007|404
Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?
|Translational Psychiatry|2022|392
The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl– channels
|Journal of Clinical Investigation|2010|291